概括
目前的药物不良反应 (ADR) 数据不足以做出可靠的结论. 需要更严格的研究来准确评估副作用及其对患者健康的影响.
科学领域:
- 药物监督 药物监督 药物监督
- 临床流行病学 临床流行病学
- 药品安全 药品安全
背景情况:
- 关于药物不良反应 (ADRs) 的现有数据不足,缺乏代表性,控制和明确的识别标准.
- 目前的ADR数据阻止了关于发病率,死亡率或因果关系的有效定量结论.
- 将目前的ADR数据推断到一般人群是科学上不合理的,并且可能具有误导性.
研究的目的:
- 突出目前药物不良反应 (ADR) 数据中的关键缺陷.
- 为准确的ADR评估提出必要的方法改进.
- 强调需要在药物治疗中进行均衡的风险效益分析.
主要方法:
- 批评现有的ADR数据质量和方法.
- 与代表性人口 (医院和门诊) 进行前性研究的建议.
- 关于ADR研究中经营性定义的标准和控制组的建议.
主要成果:
- 目前的ADR数据是不完整的,不代表性的和不受控制的.
- 关于ADR相关的发病率,死亡率或原因,无法得出可靠的定量结论.
- 现有数据的推断是无效的,可能会误导.
结论:
- 准确评估ADR需要对代表性人群进行研究,使用定义的标准和控制.
- 进一步的研究对于了解ADRs的真正范围和影响至关重要.
- 评估药物益处的研究也需要进行全面的风险-益处观点.
相关概念视频
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Effects of Chemicals: Overview
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...


